© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
February 2014
Fine Print of Budget Deal Doesn't Bode Well for SGR Overhaul
February 12, 2014
Article
Evidence-Based Oncology
Immunotherapy in Cancer Care: Understanding the Impact of Shifting Treatment Paradigms in the Managed Care Setting
February 12, 2014
Article
Evidence-Based Oncology
Post Marketing Research No Longer an Afterthought With Targeted Therapies
February 12, 2014
Article
Evidence-Based Oncology
Promising Results Halt Phase III Studies of Idelalisib
February 12, 2014
Article
Evidence-Based Oncology
When Less Is More: Results Herald 'Paradigm Shift' in Treating Newly Diagnosed Multiple Myeloma Patients
February 12, 2014
Article
Evidence-Based Oncology
Adjuvant Pre- or Post-Operative Chemotherapy Does Not Improve Survival in Rectal Cancer
February 12, 2014
Article
Evidence-Based Oncology
Collaboration Between Academia and Pharma to Bring New Therapies to Market More Important Than Ever
February 12, 2014
Article
Evidence-Based Oncology
As Genomics Reveals Diversity of Lymphomas, Questions Arise on Diagnosis, Treatment, and Ethical Issues
February 12, 2014
Article
Evidence-Based Oncology
In Cancer and Beyond, Washington State Making the Transition to Value- Based Care
February 11, 2014
Article
Evidence-Based Oncology
Sorting Out What Makes Sense in Diagnosing, Treating Prostate Cancer
February 11, 2014
Article
Evidence-Based Oncology
Defining, Measuring, and Paying for the Work of Oncology Patient Navigators
February 11, 2014
Article
Evidence-Based Oncology
A Test to Prevent Repeat Prostate Biopsies? Perhaps, if the Bar of 'Clinical Utility' Can Be Met
February 11, 2014
Article
Evidence-Based Oncology